A novel device for target controlled administration and reflection of desflurane--the Mirus™
H Bomberg, M Glas, V H Groesdonk, M Bellgardt, J Schwarz, T Volk, A Meiser, H Bomberg, M Glas, V H Groesdonk, M Bellgardt, J Schwarz, T Volk, A Meiser
Abstract
The Anaconda™ system is used to deliver inhalational sedation in the intensive care unit in mainland Europe. The new Mirus™ system also uses a reflector like the Anaconda; however, it also identifies end-tidal concentrations from the gas flow, injects anaesthetics during early inspiration, controls anaesthetic concentrations automatically, and can be used with desflurane, which is not possible using the Anaconda. We tested the Mirus with desflurane in the laboratory. Compared with an external gas monitor, the bias (two standard deviations) of the end-tidal concentration was 0.11 (0.29)% volume. In addition, automatic control was reasonable and maximum concentration delivered was 10.2%, which was deemed to be sufficient for clinical use. Efficiency was > 80% and was also deemed to be acceptable, but only when delivering a low concentration of desflurane (≤ 1.8%). By modifying the reflector, we improved efficiency up to a concentration of 3.6%. The Mirus appears to be a promising new device for long-term sedation with desflurane on the intensive care unit, but efficiency must be improved before routine clinical use becomes affordable.
© 2014 The Authors. Anaesthesia published by John Wiley & Sons Ltd on behalf of Association of Anaesthetists of Great Britain and Ireland.
Figures
References
- Kong KL, Willatts SM, Prys-Roberts C. Isoflurane compared with midazolam for sedation in the intensive care unit. British Medical Journal. 1989;298:1277–80.
- Misra S, Koshy T. A review of the practice of sedation with inhalational anaesthetics in the intensive care unit with the AnaConDa device. Indian Journal of Anaesthesia. 2012;56:518–23.
- Sackey PV, Martling CR, Granath F, Radell PJ. Prolonged isoflurane sedation of intensive care unit patients with the Anesthetic Conserving Device. Critical Care Medicine. 2004;32:2241–6.
- Meiser A, Bellgardt M, Belda J, Rohm K, Laubenthal H, Sirtl C. Technical performance and reflection capacity of the anaesthetic conserving device – a bench study with isoflurane and sevoflurane. Journal of Clinical Monitoring and Computing. 2009;23:11–9.
- Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Critical Care Medicine. 2013;41:263–306.
- Martin J, Heymann A, Basell K, et al. Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care. German Medical Science. 2010;8:Doc02.
- Bennett JA, Lingaraju N, Horrow JC. Elderly patients recover more rapidly from desflurane than from isoflurane anesthesia. Journal of Clinical Anesthesia. 1992;4:378–81.
- Tsai SK, Lee C, Kwan WF, Chen BJ. Recovery of cognitive functions after anaesthesia with desflurane or isoflurane and nitrous oxide. British Journal of Anaesthesia. 1992;69:255–8.
- Perbet S, Bourdeaux D, Sautou V, et al. A pharmacokinetic study of 48-hour sevoflurane inhalation using a disposable delivery system (AnaConDa) in ICU patients. Minerva Anestesiologica. 2014;80:655–65.
- Rohm KD, Mengistu A, Boldt J, Mayer J, Beck G, Piper SN. Renal integrity in sevoflurane sedation in the intensive care unit with the anesthetic-conserving device: a comparison with intravenous propofol sedation. Anesthesia and Analgesia. 2009;108:1848–54.
- Meiser A, Bellgardt M, Vogelsang H, Sirtl C, Weber T. Functioning of the Anaesthetic Conserving Device – aspects to consider for its use for inhalational sedation. Der Anaesthesist. 2010;59:1029–40.
- Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–10.
- Meiser A, Laubenthal H. Inhalational anaesthetics in the ICU: theory and practice of inhalational sedation in the ICU, economics, risk-benefit. Best Practice and Research: Clinical Anaesthesiology. 2005;19:523–38.
- Ebert TJ, Perez F, Uhrich TD, Deshur MA. Desflurane-mediated sympathetic activation occurs in humans despite preventing hypotension and baroreceptor unloading. Anesthesiology. 1998;88:1227–32.
- Weiskopf RB, Moore MA, Eger EI, et al. Rapid increase in desflurane concentration is associated with greater transient cardiovascular stimulation than with rapid increase in isoflurane concentration in humans. Anesthesiology. 1994;80:1035–45.
- Mapleson WW. Effect of age on MAC in humans. British Journal of Anaesthesia. 1996;76:185.
- Rohm KD, Wolf MW, Schollhorn T, Schellhaass A, Boldt J, Piper SN. Short-term sevoflurane sedation using the Anaesthetic Conserving Device after cardiothoracic surgery. Intensive Care Medicine. 2008;34:1683–9.
- Thomasson R, Luttrop HH, Werner O. A reflection filter for isoflurane and other anaesthetic vapours. European Journal of Anaesthesiology. 1989;6:89–94.
- Enlund M, Wiklund L, Lambert H. A new device to reduce the consumption of a halogenated anaesthetic agent. Anaesthesia. 2001;56:429–32.
Source: PubMed